LncRNAs and neoplasia

Clinica Chimica Acta; International Journal of Clinical Chemistry
Mustafa Isin, Nejat Dalay

Abstract

Long noncoding RNAs are emerging as new mediators of tumorigenesis by virtue of their various functions and their capacity to induce different mechanisms as a result of their wide spectrum of interactions. They play critical roles in a broad range of cellular processes including regulation of gene expression, imprinting, chromatin modification, transcription and posttranslational processing. Expression and activity of lncRNAs are deregulated in several types of human cancer. Impairment of lncRNA activity may affect key components of the cellular gene regulatory networks and is associated with deregulation of a large number of cellular oncogenic pathways. LncRNAs are also being evaluated as diagnostic and prognostic biomarkers and may provide targets for potential therapeutic applications. An improved understanding of the roles played by lncRNAs in cancer will lead to more effective therapeutic strategies. In this review we summarize the current knowledge on lncRNAs and their function as mediators of tumor development.

References

Jan 1, 1990·Molecular and Cellular Biology·C I BrannanS M Tilghman
Oct 3, 1999·The Journal of Biological Chemistry·M A FrevelA E Reeve
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·V SrikantanS Srivastava
Feb 24, 2001·Molecular Pathology : MP·I ArielA Hochberg
Apr 24, 2002·Archives of Disease in Childhood·P R Reynolds
Jun 20, 2003·European Urology·Daphne HesselsJack A Schalken
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Xun ZhangAnne Klibanski
Jun 19, 2004·Genomics·Raluca I Verona, Marisa S Bartolomei
Jul 9, 2004·Carcinogenesis·Anna IacoangeliHenri Tiedge
Jul 13, 2004·European Urology·Martina TinzlCamille Chypre
Jul 20, 2004·Nature Biotechnology·Erez Y LevanonMichael F Jantsch
Nov 24, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Carsten Müller-TidowHubert Serve
Mar 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peggy S EisJames E Dahlberg
Jun 30, 2005·The Journal of Biological Chemistry·Nathalie BerteauxEric Adriaenssens
Jul 19, 2005·Genes & Development·Emily Bernstein, C David Allis
Jan 31, 2006·Cancer Science·Kazumi YamadaMasayuki Noguchi
Mar 24, 2006·Nature·Ilya ShamovskyEvgeny Nudler
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jian-Hua LuoGeorge K Michalopoulos
Sep 6, 2007·PloS One·Imad J MatoukEithan Galun
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yinghui GuanJoe W Gray

❮ Previous
Next ❯

Citations

Feb 11, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Michael SandSchapoor Hessam
Dec 24, 2015·Molecular Cancer·Norma I Rodríguez-MalavéDinesh S Rao
Mar 18, 2016·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·David E Amacher
May 9, 2016·The Journal of Nutritional Biochemistry·Estanislau NavarroHelmut Schröder
Oct 27, 2016·Journal of Cellular and Molecular Medicine·Ledong WanHonghe Zhang
Jul 20, 2016·Cancer Biomarkers : Section a of Disease Markers·Anbang HeYuchen Liu
Aug 16, 2016·Journal of Experimental & Clinical Cancer Research : CR·Anbang HeHongbing Mei
Oct 6, 2018·Cell Proliferation·Anbang HeLiqun Zhou
Dec 17, 2015·World Journal of Hepatology·Yong-Ru LiuGang Chen
Sep 22, 2017·World Journal of Gastroenterology : WJG·Zhao-Shan NiuWen-Hong Wang
May 8, 2019·Applied Microbiology and Biotechnology·Chit TamTzi Bun Ng
Apr 25, 2020·International Journal of Molecular Sciences·Young-Ah KimSun-Jae Lee
Jan 27, 2017·Oncology Letters·Hongwu FanXiaoyu Yang
Mar 15, 2018·Journal of Biomedical Science·Cheng SunYunfu Cui
Oct 24, 2018·Frontiers in Neuroscience·Ying ZhangFeng-Xu Yu
Jan 22, 2020·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Yaqiong ZhangBo Li
Feb 6, 2020·Clinical and Translational Medicine·Estanislao NavarroMiguel Hueso
Nov 1, 2020·Cells·Christian T StackhouseChristopher D Willey
Apr 6, 2021·BioMed Research International·Biyong DengHouping Chen
Jul 3, 2021·International Journal of Molecular Sciences·Riccardo Di FioreJean Calleja-Agius
Aug 8, 2021·International Journal of Molecular Sciences·Riccardo Di FioreJean Calleja-Agius
Aug 3, 2021·Experimental and Therapeutic Medicine·Yuanjie ZhangGang Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

International Journal of Molecular Sciences
Nina Hauptman, Damjan Glavač
Molecular and Clinical Oncology
Fu-Jun YuXiao-Ming Fan
Journal of Hematology & Oncology
Hua ZhangYue-Qin Chen
© 2022 Meta ULC. All rights reserved